Results 171 to 180 of about 21,545 (230)

Genetic testing and evidence of a founder mutation in a hotspot for hereditary transthyretin amyloidosis. [PDF]

Sci Rep
Ventayol-Guirado M, Cisneros-Barroso E, Ribot-Sanso MA, Gonzalez-Moreno J, Losada I, Ripoll-Vera T, Pons J, Fortuny E, Bosch T, Figuerola A, Descals C, Montala JC, Alvarez-Rubio J, Hernandez-Rodriguez J, Lustre-Rodriguez J, Llull-Alberti MV, Jimenez-Barcelo JA, Asensio-Landa VJ, Torres-Juan L, Martinez-Lopez I, Buades-Reines J, Heine-Suñer D.   +21 more
europepmc   +1 more source

Case report and literature review of transthyretin amyloidosis with p.Ser43Asn mutation presenting in China. [PDF]

Front Cardiovasc Med
Abulikemu K, Hong L, Zhong Q.
europepmc   +1 more source

A rare presentation of pulmonary transthyretin amyloidosis. [PDF]

Respir Med Case Rep
Assaad M, Acharya R, Springsted E, Biscardi F.   +3 more
europepmc   +1 more source

A new staging system for hereditary transthyretin amyloidosis in the era of specific amyloidosis therapies. [PDF]

ESC Heart Fail
Neculae G, Zaroui A, Adam R, Kharoubi M, Funalot B, Coriu D, Jurcut R, Damy T.   +7 more
europepmc   +1 more source

Vitreous Opacities in Familial Transthyretin Amyloidosis. [PDF]

Dtsch Arztebl Int
Auw-Haedrich C, Neß T.
europepmc   +1 more source

Long-Term Peritoneal Dialysis in Hereditary Transthyretin Amyloidosis: A Case Report and Management Challenges. [PDF]

Cureus
Fernandes V, Paulo N, Silva R, Oliveira A, Beco A, Pestana M.   +5 more
europepmc   +1 more source

Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosis. [PDF]

Eur Heart J
Nitsche C, Dobner S, Rosenblum HR, Patel KP, Longhi S, Yilmaz A, Merlo M, Papathanasiou M, Griffin J, Oerlemans MIFJ, Gama F, Hamdan A, Kelion AD, Schuster A, Glaveckaité S, Akyol N, Porcari A, Schlender L, Capovilla T, Autherith M, Hauptmann L, Halavina K, Cavalcante JL, Fontana M, Scully PR, Moon JC, Mascherbauer J, Ristl R, Biagini E, Stortecky S, Maurer MS, Treibel TA, AS-Amyloidosis Consortium .   +32 more
europepmc   +1 more source

Genetic and clinical features of hereditary transthyretin amyloidosis: a decade of experience at a Japanese referral center. [PDF]

Orphanet J Rare Dis
Nomura T, Misumi Y, Tasaki M, Yamakawa S, Taguchi T, Obayashi K, Yamashita T, Ando Y, Ueda M.   +8 more
europepmc   +1 more source

Clinical utility of neurofilament light chain as a biomarker for disease onset and progression in hereditary transthyretin amyloidosis. [PDF]

Front Neurol
Gragera-Martínez Á, Borrachero Garro C, Muñoz Beamud F, Manovel Sánchez A, González Macías A, Pizarro Sánchez M, Jiménez Heffernan A, Serrano Mira A, Macías Dominguez B, Garcia Garrido S.   +9 more
europepmc   +1 more source